P
WST icon

&Partners’s West Pharmaceutical WST Stock Holding History

&Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.79M Buy
23,053
+2,607
+13% +$649K 0.03% 481
2025
Q4 		$5.63M Buy
20,446
+14,753
+259% +$4.04M 0.03% 462
2025
Q3 		$4.56M Buy
5,693
+190
+3% +$46.2K 0.03% 455
2025
Q2 		$1.2M Buy
5,503
+1,256
+30% +$268K 0.01% 888
2025
Q1 		$943K Buy
4,247
+1,311
+45% +$361K 0.01% 857
2024
Q4 		$985K Buy
2,936
+268
+10% +$84.3K 0.01% 773
2024
Q3 		$801K Buy
2,668
+682
+34% +$209K 0.02% 657
2024
Q2 		$654K Buy
+1,986
New +$702K 0.03% 458

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

&Partners's WST Position: Q1 2026 in Review

&Partners increased its West Pharmaceutical (WST) stake by 13% in Q1 2026, buying an estimated $649K and bringing the position to 23,053 shares worth $5.79M. The position accounts for 0.03% of the portfolio, ranked #481.

&Partners first reported a position in WST in Q2 2024 and has held it in 8 quarters since. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • &Partners held 23,053 shares of West Pharmaceutical worth $5.79M as of Q1 2026.
  • &Partners bought 2,607 West Pharmaceutical shares in Q1 2026, an estimated $649K.
  • West Pharmaceutical made up 0.03% of &Partners's portfolio in Q1 2026, its #481 holding.
  • &Partners first reported a position in West Pharmaceutical in Q2 2024 and has held it in 8 quarters since.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.